✦ LIBER ✦

Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms—long-term follow-up of a placebo-controlled, double-blind, multicenter trial

✍ Scribed by Nikolai Lopatkin; Andrey Sivkov; Sandra Schläfke; Petra Funk; Alexander Medvedev; Udo Engelmann

Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 200 KB
Volume: 39
Category: Article
ISSN: 0301-1623
DOI: 10.1007/s11255-006-9173-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of a combi

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial

✍ N. Lopatkin; A. Sivkov; C. Walther; S. Schläfke; A. Medvedev; J. Avdeichuk; G. G 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 323 KB

Safety and efficacy of long-term intraar

Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial

✍ Jean-Pierre Raynauld; Chris Buckland-Wright; Rupert Ward; Denis Choquette; Boulo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Efficacy and safety of rebamipide for th

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

✍ Susumu Sugai; Hiroki Takahashi; Shuji Ohta; Makoto Nishinarita; Masami Takei; Sh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 413 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

Safety and efficacy of deep brain stimul

Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

✍ Denys Fontaine; Yves Lazorthes; Patrick Mertens; Serge Blond; Gilles Géraud; Nel 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 267 KB